0 Comments
0 Shares
55 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Comments 0 Shares 888 Views 0 Reviews
-
Cervical Cancer Treatment Market Outlook 2025–2033: Growth, Trends & ForecastMarket Overview The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8% during the forecast period (2025-2033). The global Cervical Cancer Treatment market continues to evolve rapidly, driven by shifting...0 Comments 0 Shares 2K Views 0 Reviews
-
Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired InfectionsAccording to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...0 Comments 0 Shares 567 Views 0 Reviews
-
Global DXM and Codeine Syrup Market to Reach USD 2.75 Billion by 2034 Amid Rising Respiratory IllnessesAccording to a new report from Intel Market Research, the global DXM and Codeine Syrup market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.75 billion by 2034, growing at a CAGR of 7.2% during the forecast period (2026-2034). This growth is driven by increasing respiratory illness prevalence, rising healthcare expenditure in emerging economies, and expanding...0 Comments 0 Shares 623 Views 0 Reviews
-
Global Gelatin Market to Reach USD 5.90 Billion by 2032 Driven by Pharma, Food, and Clean-Label DemandAccording to a new report from Intel Market Research, the global gelatin market was valued at USD 3.64 billion in 2024 and is projected to reach USD 5.90 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032). This growth is fueled by increasing demand across food & beverage, pharmaceutical, and cosmetic applications, coupled with gelatin's versatile functional...0 Comments 0 Shares 825 Views 0 Reviews
-
Global Neomycin Market Set to Reach USD 620 Million by 2034 Amid Rising Infection BurdenAccording to a new report from Intel Market Research, the global Neomycin market was valued at USD 420 million in 2025 and is projected to reach USD 620 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2026–2034). This growth is fueled by rising antibiotic demand in human healthcare and veterinary medicine, coupled with increasing prevalence of bacterial...0 Comments 0 Shares 819 Views 0 Reviews
-
Global Pirfenidone Tablets Market to Reach USD 2.08 Billion by 2034 Amid Rising IPF CasesAccording to a new report from Intel Market Research, the global Pirfenidone Tablets market was valued at USD 1.05 billion in 2025 and is projected to reach USD 2.08 billion by 2034, growing at a strong CAGR of 7.8% during the forecast period (2026–2034). This growth is driven by increasing prevalence of idiopathic pulmonary fibrosis (IPF), expanding geriatric population, and improved...0 Comments 0 Shares 786 Views 0 Reviews
-
Global Recombinant Human Insulin Market to Reach USD 9.7 Billion by 2034 Amid Rising Diabetes BurdenAccording to a new report from Intel Market Research, the global Recombinant Human Insulin market was valued at USD 5.8 billion in 2025 and is projected to reach USD 9.7 billion by 2034, growing at a CAGR of 5.6% during the forecast period (2026–2034). This sustained growth reflects the increasing global burden of diabetes and the shift toward biotechnology-derived insulin therapies that...0 Comments 0 Shares 864 Views 0 Reviews
-
Global Romiplostim Market to Reach USD 2.75 Billion by 2034 Driven by Rising ITP CasesAccording to a new report from Intel Market Research, the global Romiplostim market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.75 billion by 2034, growing at a steady CAGR of 7.2% during the forecast period (2026-2034). This growth trajectory reflects the rising global burden of chronic immune thrombocytopenia (ITP) and increasing adoption of targeted biologic...0 Comments 0 Shares 626 Views 0 Reviews
-
Global Topical Pain Killers Market to Reach $12.9 Billion by 2034 Amid Rising Chronic Pain CasesAccording to a new report from Intel Market Research, the global topical pain killers market was valued at USD 7.5 billion in 2025 and is projected to reach USD 12.9 billion by 2034, growing at a CAGR of 6.3% during the forecast period (2026–2034). This growth is driven by increasing prevalence of chronic pain conditions, rising geriatric population, and growing preference for...0 Comments 0 Shares 799 Views 0 Reviews
-
Global Trospium Chloride Market to Reach USD 49.7 Million by 2034 Amid Rising OAB CaseAccording to a new report from Intel Market Research, the global Trospium Chloride market was valued at USD 36.9 million in 2024 and is projected to reach USD 49.7 million by 2034, growing at a steady CAGR of 4.4% during the forecast period (2025-2034). This growth is driven by increasing overactive bladder (OAB) prevalence, aging populations requiring urological care, and pharmaceutical...0 Comments 0 Shares 617 Views 0 Reviews
-
Inside the Viral Vector Manufacturing Market: 19.7% CAGR Growth Forecast ExplainedMarket Overview The global viral vector manufacturing market size was valued at USD 267.8 million in 2024 and is expected to grow from USD 336.36 million in 2025 to USD 3189.15 million by 2033, growing at a CAGR of 19.7% during the forecast period (2025-2033). The growth of the market is attributed to growth in the genetic disorder. The global Viral...0 Comments 0 Shares 2K Views 0 Reviews
More Results
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek